ATLANTA, GA--(MARKET WIRE)--Jun 12, 2007 -- AtheroGenics, Inc. (NasdaqGM:AGIX - News), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today announced its participation in the upcoming Sixth Annual Needham Biotechnology & Medical Technology Conference on Wednesday, June 13, 2007, at 8:00 a.m. EDT at The New York Palace Hotel in New York City.
